Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.83 USD
−217.57 M USD
100.39 M USD
48.33 M
About 2seventy bio, Inc.
Sector
CEO
William Denise Baird
Headquarters
Cambridge
Website
Founded
2021
FIGI
BBG00YV1J622
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TSVT is 3.14 USD — it has increased by 7.53% in the past 24 hours. Watch 2seventy bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 2seventy bio, Inc. stocks are traded under the ticker TSVT.
TSVT stock has fallen by −5.14% compared to the previous week, the month change is a −2.48% fall, over the last year 2seventy bio, Inc. has showed a −9.25% decrease.
We've gathered analysts' opinions on 2seventy bio, Inc. future price: according to them, TSVT price has a max estimate of 10.00 USD and a min estimate of 2.00 USD. Watch TSVT chart and read a more detailed 2seventy bio, Inc. stock forecast: see what analysts think of 2seventy bio, Inc. and suggest that you do with its stocks.
TSVT reached its all-time high on Nov 4, 2021 with the price of 64.00 USD, and its all-time low was 1.54 USD and was reached on Nov 22, 2023. View more price dynamics on TSVT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TSVT stock is 11.15% volatile and has beta coefficient of 3.18. Track 2seventy bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is 2seventy bio, Inc. there?
Today 2seventy bio, Inc. has the market capitalization of 161.99 M, it has decreased by −13.94% over the last week.
Yes, you can track 2seventy bio, Inc. financials in yearly and quarterly reports right on TradingView.
2seventy bio, Inc. is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
TSVT earnings for the last quarter are −0.19 USD per share, whereas the estimation was −0.19 USD resulting in a 1.63% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about 2seventy bio, Inc. earnings.
2seventy bio, Inc. revenue for the last quarter amounts to 13.53 M USD, despite the estimated figure of 16.18 M USD. In the next quarter, revenue is expected to reach 14.70 M USD.
TSVT net income for the last quarter is −9.93 M USD, while the quarter before that showed 24.88 M USD of net income which accounts for −139.93% change. Track more 2seventy bio, Inc. financial stats to get the full picture.
No, TSVT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 274.00 employees. See our rating of the largest employees — is 2seventy bio, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 2seventy bio, Inc. EBITDA is −133.86 M USD, and current EBITDA margin is −205.62%. See more stats in 2seventy bio, Inc. financial statements.
Like other stocks, TSVT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 2seventy bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 2seventy bio, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 2seventy bio, Inc. stock shows the sell signal. See more of 2seventy bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.